Daniel G Calame,Jovi Huixin Wong,Puravi Panda,Dat Tuan Nguyen,Nancy C P Leong,Riccardo Sangermano,Sohil G Patankar,Mohamed Abdel-Hamid,Lama AlAbdi,Sylvia Safwat,Kyle P Flannery,Zain Dardas,Jawid M Fatih,Chaya Murali,Varun Kannan,Timothy E Lotze,Isabella Herman,Farah Ammouri,Brianna Rezich,Stephanie Efthymiou,Shahryar Alavi,David Murphy,Zahra Firoozfar,Mahya Ebrahimi Nasab,Amir Bahreini,Majid Ghasemi,Nourelhoda A Haridy,Hamid Reza Goldouzi,Fatemeh Eghbal,Ehsan Ghayoor Karimiani,Varunvenkat M Srinivasan,Vykuntaraju K Gowda,Haowei Du,Shalini N Jhangiani,Zeynep Coban-Akdemir,Dana Marafi,Lance Rodan,Sedat Isikay,Jill A Rosenfeld,Subhadra Ramanathan,Michael Staton,Kerby C Oberg,Robin D Clark,Catharina Wenman,Sam Loughlin,Ramy Saad,Tazeen Ashraf,Alison Male,Shereen Tadros,Reza Boostani,Ghada M H Abdel-Salam,Maha Zaki,Ebtesam Abdalla,M Chiara Manzini,Davut Pehlivan,Jennifer E Posey,Richard A Gibbs,Henry Houlden,Fowzan S Alkuraya,Kinga Bujakowska,Reza Maroofian,James R Lupski,Long Nam Nguyen

Abstract:FLVCR1 encodes Feline leukemia virus subgroup C receptor 1 (FLVCR1), a solute carrier (SLC) transporter within the Major Facilitator Superfamily. FLVCR1 is a widely expressed transmembrane protein with plasma membrane and mitochondrial isoforms implicated in heme, choline, and ethanolamine transport. While Flvcr1 knockout mice die in utero with skeletal malformations and defective erythropoiesis reminiscent of Diamond-Blackfan anemia, rare biallelic pathogenic FLVCR1 variants are linked to childhood or adult-onset neurodegeneration of the retina, spinal cord, and peripheral nervous system. We ascertained from research and clinical exome sequencing 27 individuals from 20 unrelated families with biallelic ultra-rare missense and predicted loss-of-function (pLoF) FLVCR1 variant alleles. We characterize an expansive FLVCR1 phenotypic spectrum ranging from adult-onset retinitis pigmentosa to severe developmental disorders with microcephaly, reduced brain volume, epilepsy, spasticity, and premature death. The most severely affected individuals, including three individuals with homozygous pLoF variants, share traits with Flvcr1 knockout mice and Diamond-Blackfan anemia including macrocytic anemia and congenital skeletal malformations. Pathogenic FLVCR1 missense variants primarily lie within transmembrane domains and reduce choline and ethanolamine transport activity compared with wild-type FLVCR1 with minimal impact on FLVCR1 stability or subcellular localization. Several variants disrupt splicing in a mini-gene assay which may contribute to genotype-phenotype correlations. Taken together, these data support an allele-specific gene dosage model in which phenotypic severity reflects residual FLVCR1 activity. This study expands our understanding of Mendelian disorders of choline and ethanolamine transport and demonstrates the importance of choline and ethanolamine in neurodevelopment and neuronal homeostasis.

Structural basis of lipid head group entry to the Kennedy pathway by FLVCR1

Molecular mechanism of choline and ethanolamine transport in humans

Turnover of Nonessential Fatty Acids in Cardiolipin from the Rat Heart.

Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders

Structural basis for catalysis and selectivity of phospholipid synthesis by eukaryotic choline-phosphotransferase

Human TMEM30a Promotes Uptake of Antitumor and Bioactive Choline Phospholipids into Mammalian Cells

Structural basis for catalysis of human choline/ethanolamine phosphotransferase 1

Biallelic variation in the choline and ethanolamine transporter underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders

Structural Mechanisms of Human Sodium-Coupled High-Affinity Choline Transporter CHT1

Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum

The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3

Structure and mechanism of blood–brain-barrier lipid transporter MFSD2A

Structural basis for defective membrane targeting of mutant enzyme in human VLCAD deficiency

MFSD7c functions as a transporter of choline at the blood–brain barrier

Differential contributions of phosphotransferases CEPT1 and CHPT1 to phosphatidylcholine homeostasis and lipid droplet biogenesis

Substrate specificity controlled by the exit site of human P4-ATPases, revealed by de novo point mutations in neurological disorders

A partnership between the lipid scramblase XK and the lipid transfer protein VPS13A at the plasma membrane

Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia

Structural and Functional Insights of the Human Peroxisomal ABC Transporter ALDP

CLCC1 promotes hepatic neutral lipid flux and nuclear pore complex assembly

CLCC1 Governs Bilayer Equilibration at the Endoplasmic Reticulum to Maintain Cellular and Systemic Lipid Homeostasis